How Long It Takes to Launch a Cosmetic in Each Market
Realistic lead times from Canada's fast notification system to markets that take months, so you can sequence a launch properly.
Somebody planning a multi-country launch asked me to just give them a spreadsheet: market on one side, weeks-to-launch on the other. I get why. Everyone wants to book a launch date and work backward. The honest answer is that "how long" depends heavily on which regulatory model a market uses, and those models are genuinely different in kind, not just in speed.
Two very different regulatory shapes
Broadly, markets fall into two camps. Some use a notification model: you tell the regulator what you're selling, you don't wait for their approval, and you can generally go to market almost immediately as long as your paperwork and safety file are in order. Others use a registration or pre-approval model: you submit, and you wait for the regulator to actually review and clear the product before it can legally be sold.
That distinction matters more than any specific number of days, because it changes whether your bottleneck is your own paperwork speed or someone else's review queue.
Canada: fast, notification-based
Health Canada's system is a genuine notification model. You file your Cosmetic Notification Form through the Cosmetic Notification System, and the requirement is that it be filed within 10 days of first sale, not 10 days before. That structure tells you something important: Canada isn't asking you to wait for a green light. You're required to notify them close to when you actually start selling, and you get back a Cosmetic Notification (CN) number as confirmation. This makes Canada one of the faster markets to plan around, assuming your ingredient list is clean against the Cosmetic Ingredient Hotlist and your label meets the bilingual English/French requirement.
United States: registration and listing, not pre-clearance
Under MoCRA, US-based responsible persons need facility registration and product listing with the FDA, along with safety substantiation and adverse event recordkeeping in place. This isn't a pre-market approval queue you sit in either, though some small businesses qualify for exemptions from registration and listing. The practical timeline driver in the US tends to be getting your own safety substantiation file in order and confirming your product doesn't cross into drug territory (sunscreen, for instance, is regulated as an OTC drug, not a cosmetic, and that's a completely different and slower pathway).
European Union: portal notification plus a real paper trail
The EU, under Regulation (EC) No 1223/2009, requires notification through the CPNP portal, but the real timeline driver here is usually the prep work before you ever touch the portal: appointing a Responsible Person established in the EU, assembling a Product Information File, and getting a Cosmetic Product Safety Report signed off by a qualified safety assessor. The portal step itself tends to move quickly. Getting a signed CPSR in place is the part that takes real lead time, especially if you're a smaller brand sourcing a safety assessor for the first time.
UK: its own post-Brexit system
The UK runs its own notification system, the OPSS Submit Cosmetic Product Notification (SCPN) service, separate from the EU's CPNP. If you're used to EU notification, don't assume UK coverage is automatic. It's a parallel filing, and timeline-wise it behaves similarly to other notification-style systems: the bottleneck is your own file readiness, not a long regulator queue.
Australia: a different model entirely
AICIS doesn't work like a per-product notification system at all. It regulates cosmetic ingredients as industrial chemicals through an Inventory and introduction categories. That's a structurally different question from "how long until my lipstick can launch," and conflating the two is one of the more common planning mistakes I see. Your timeline here depends on whether your ingredients are already on the Inventory or need to go through an introduction category, which is an ingredient-level question, not a finished-product one.
A rough sequencing guide
| Market | Model type | What actually drives your timeline |
|---|---|---|
| Canada | Notification | Your own filing speed; CNF due within 10 days of first sale |
| United States | Registration and listing (MoCRA) | Facility registration, safety file readiness, drug/cosmetic classification |
| European Union | Notification via CPNP | Getting a Responsible Person, PIF, and signed CPSR in place |
| United Kingdom | Notification via SCPN | Separate filing from EU; your own file readiness |
| Australia | Ingredient-level (AICIS) | Whether ingredients are already on the Inventory |
The planning takeaway
If you're sequencing a multi-market launch, lead with the markets where your own paperwork is the bottleneck, since those move as fast as you do. Markets with a heavier upfront documentation requirement, or an ingredient-level system like Australia's, deserve to be started earlier in your planning even if you intend to launch there last. And always confirm current requirements and timelines directly with each market's regulator, since these details and thresholds do shift over time.
Cosmetic Comply currently handles Canada's notification process end to end, with the US, EU, and Australia in development, which is useful if you're trying to sequence a launch across markets that work on genuinely different clocks.
Send your ingredients and we take it from here
A short intake form is all it takes to start. Every ingredient gets checked against your market's prohibited and restricted lists, then we file your notification and hand you a number you can track.
Start a filingKeep reading
Northern Ireland Cosmetic Rules Are Not the Same as Britain
Selling across the whole UK from one label? Northern Ireland still follows EU cosmetic rules while Great Britain runs its own separate system.
Korean Language Labeling Rules for Imported Cosmetics
Selling into Korea means a Korean-language label the importer applies, and its ingredient names do not map one-to-one with INCI.
Why Sunscreen Is a Drug in Some Markets and a Cosmetic in Others
How the US, EU, and Australia treat SPF products differently, and where sunscreen claims can knock your notification out of the cosmetic lane.
Labeling a Cosmetic in Multiple Languages Without Errors
Which label elements must be translated in Canada, the EU, and the Gulf, and why INCI ingredient names stay in a single fixed form everywhere.